InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+14.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Throne Jason, Vice-Président Exécutif et Conseiller Juridique. Director active across 1 company, notably IDEAYA Biosciences, Inc.. In total, 13 filings have been logged. History available since 6 July 2021. The latest transaction was filed on 27 June 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations13 total
6,424 shares@ US$13.3411.2% of flowCommon StockSEC:0001610717-24-000367:0
10,000 shares@ US$13.3417.0% of flowCommon StockSEC:0001610717-23-000406:0
5,163 shares@ US$12.868.8% of flowCommon StockSEC:0001610717-23-000322:0
1,000 shares@ US$12.861.7% of flowCommon StockSEC:0001610717-23-000279:0
2,100 shares@ US$12.863.5% of flowCommon StockSEC:0001610717-23-000258:0
5,000 shares@ US$13.348.5% of flowCommon StockSEC:0001610717-23-000226:0
4,485 shares@ US$7.014.0% of flowCommon StockSEC:0001610717-23-000204:0
432 shares@ US$7.010.4% of flowCommon StockSEC:0001610717-23-000087:0
500 shares@ US$7.010.5% of flowCommon StockSEC:0001610717-23-000063:0
10,000 shares@ US$13.340.0046% mcap35.7% of flowCommon StockSEC:0001567619-21-014176:0
10,000 shares@ US$13.3415.8% of flowCommon StockSEC:0001567619-21-014176
7,610 shares@ US$7.010.0018% mcap14.3% of flowCommon StockSEC:0001567619-21-013155:0
7,610 shares@ US$7.016.3% of flowCommon StockSEC:0001567619-21-013155
13 of 13 declarations
About Throne Jason
Jason Throne is the Executive Vice President and General Counsel at IDEAYA Biosciences, Inc. He oversees the company's legal and regulatory affairs, ensuring compliance and protection of the company's interests. With expertise in business law, he plays an essential role in managing legal risks and the overall strategy of IDEAYA. His experience contributes to achieving the company's objectives.
